Tadd Lazarus has joined cancer tests company Clinical Genomics as chief medical officer. Before coming to the Bridgewater, NJ-based company, Lazarus was senior vice president and chief medical officer for Luminex (NASDAQ: [[ticker:LMNX]]), an Austin, TX, firm that develops and sells biological testing technologies. Clinical Genomics markets tests for colorectal cancer.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan